Participant flow11

How many started, completed or left each group, period by period.

1 to 11 of 11

Period	Milestone	Group	Participants
Qualification Phase	STARTED	All Subjects	78
Qualification Phase	COMPLETED	All Subjects	54
Qualification Phase	NOT COMPLETED	All Subjects	24
Treatment Phase	STARTED	All Subjects	41
Treatment Phase	Placebo	All Subjects	38
Treatment Phase	Oxymorphone ER 15 mg	All Subjects	37
Treatment Phase	Oxymorphone ER 30 mg	All Subjects	38
Treatment Phase	Oxycodone CR 30 mg	All Subjects	40
Treatment Phase	Oxycodone CR 60 mg	All Subjects	40
Treatment Phase	COMPLETED	All Subjects	35
Treatment Phase	NOT COMPLETED	All Subjects	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00955110/flow